Inhibition of the JAK/STAT3 pathway in gastric tumor tissues reduces the inflammatory response, inhibits the inflammatory cytokines IL-1L, IL-6, and IL-1β, and decreases tumor volume [43]. This evidence concerns the gene IL1B and gastric neoplasm.